Navigation Links
drugstore.com inc. Reports Solid Revenue Growth and Record Gross Margins in the Third Quarter of 2008
Date:11/5/2008

improved 230 basis points to 31.6% year-over-year."

"Our sales growth was in-line with our previous guidance, but we did see an overall impact from the slowdown in the economy -- notably in the second half of September. While we are not recession proof, trends have improved in October, and we believe that we have a number of key differentiators, which should help fuel growth going forward. We serve a very attractive customer demographic and offer a wide selection of lower ticket items, a compelling value proposition, and a high percentage of replenishment products. Over the next three months, we should also start to see the initial benefits from the launch of two new growth initiatives: our international OTC platform and our online OTC store with Rite Aid. We believe our strengthened business model and strategic growth initiatives will position us to achieve OTC growth of over 9% and GAAP profitability in the fourth quarter of 2008," concluded Ms. Lepore.

GAAP net loss for the third quarter of 2008 was $3.6 million, or $0.04 per share, compared to a net loss of $2.4 million, or $0.02 per share, for the third quarter of 2007. The third quarter 2008 losses include $1.7 million in accelerated non-cash marketing expense, $800,000 related to consulting services, and $1.8 million in non-cash stock-based compensation expense, compared to $2.1 million in non-cash stock-based compensation expense for 2007.

For the third quarter of 2008, we reported $1.1 million of net income from our discontinued local pick-up pharmacy operations, as a result of our restructured agreement with Rite Aid announced on September 4, 2008.

Outlook for Fourth Quarter 2008

For the fourth quarter of 2008, the company is targeting net sales in the range of $94.0 million to $99.0 million, net income in the range of $400,000 to $1.9 million, and adjusted EBITDA in the range of $5.3 million to $6.8 million.

Financial and Operational Highlights for the Third Quart
'/>"/>

SOURCE drugstore.com, inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. drugstore.com, inc. to Present at Upcoming Investor Conferences
2. drugstore.com inc. Reports Results for the First Quarter of 2008
3. drugstore.com, inc. to Announce First Quarter 2008 Results During Conference Call on Monday, May 5, 2008 at 5:00 p.m. ET
4. drugstore.com, inc. to Present at the Upcoming Jefferies 4th Annual Internet Conference and the Morgan Stanley Technology Conference
5. drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
6. drugstore.com inc. Reports Record Gross Margins and Bottom Line Results for the Third Quarter of 2007
7. drugstore.com, inc. to Announce Third Quarter 2007 Results During Conference Call on Monday, October 22, 2007 at 5:00 p.m. ET
8. drugstore.com and Revolution Health Group Announce Breakthrough Deal
9. MannKind Corporation Reports Third Quarter Financial Results
10. Hospira Reports Third-Quarter 2008 Results
11. Almost Family Reports Third Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/7/2009)... BOSTON The drive toward containing health care c...cing physician productivity, impairing quality and...aconess Medical Center physicians suggest in a Ne...iting studies in behavioral economics and psycholo...xpress the fear that assigning a monetary value to...
(Date:1/7/2009)... NASHVILLE, Tenn., Jan. 7 Ambulatory Services o... purchase of additional interests in,ROSA of Georg... Radiation,Oncology Services of America, Inc., and...purchase, Radiation Oncology Services of America w... (Logo: http://www.newscom.com/cgi-bin/prnh/20...
(Date:1/7/2009)...AN ANTONIO, Jan. 7 BioMedical Enterprises, Inc. (...d on the development of orthopaedic memory metal i...neth I. Moch as its President and Chief Executive ...will become Chief Technology Officer and continue ...product offerings. , , BME specializes in nitino...
(Date:1/7/2009)...ther low levels would work for ER patients with hy...7 (HealthDay News) -- Going to the world,s most el...researchers have found that the established medica...y under stress might be wrong. , "Some people can ...r than we expected," said Dr. Michael P.W. Grocott...
Breaking Medicine News(10 mins):Health News:Cost containment focus could have consequences for health care delivery 2Health News:Ambulatory Services of America, Inc. Completes Purchase of Majority Interest in Rosa of Georgia, LLC 2Health News:BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer 2Health News:Study of Everest Climbers Questions Oxygen Use 2Health News:Study of Everest Climbers Questions Oxygen Use 3
...the September 27 issue of JAMA says that initial r...ted HIV positive patients has little or no effect ...d to conflicts in opinion as to when antiretrovira...4 cells is a characteristic of progressive human i...
... has invented a condom that plays music during sex...entist Hryhory Chausovsky developed the birth cont...easurable love-making, he said. A miniature louds...sensor implanted in the condom's upper cuff provid...
...are in remission one year after seeking profession... the next 15 years// than those who are in relapse...s also reduced for alcoholics who undergo a longer...Alcoholics Anonymous participation during the firs...
...hould put their heads together, and share vital in...ople across nationalities from a dreaded form of f...ational effort in the development of a vaccine, wh...portant information regarding influenza virus samp...
Other Medicine News:Health News:HIV RNA Level Seen As Little Value In Predicting Treatment 2Health News:First-Year Treatment Success Lowers 15-Year Death Risk for Alcoholics 2
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire/... that predict a high likelihood of relapse in chil...ough the researchers caution that further research...alled IKZF1 or IKAROS, lead to leukemia relaps...r future diagnostic tests to assess the risk of tr...
(Date:1/7/2009)..., OXFORD, England, January 7 ...pany focused on allergy and critical care, today,...ts achieved in 2008 with,its ToleroMune(R) anti-a...patient recruitment for a further phase II clinica...way in Canada, has recruited 120 patients with con...
(Date:1/6/2009)..., ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswire/...ical company focused on diseases of epidemic poten...ndidate for the treatment of tuberculosis (TB), wa...y awarded clinical program contract to Dynport Vac...contract, awarded by the National Institute of All...
(Date:1/5/2009)..., BETHESDA, Md., Jan. 5 /PRNewswire-FirstCal...maceutical company developing novel, proprietary,...on and autoimmune diseases,provides an outlook o... Micromet intends to provide an update on its ...g events: , -- April 12 to 16, 2009: Update...
Breaking Medicine Technology:Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Micromet Key Events for 2009 2Micromet Key Events for 2009 3Micromet Key Events for 2009 4Micromet Key Events for 2009 5First Quarter of 2008 3A Draeger Improves Order Intake and Net Sales 18945 1First Quarter of 2008 3A Draeger Improves Order Intake and Net Sales 18945 2First Quarter of 2008 3A Draeger Improves Order Intake and Net Sales 18945 3Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate 241 To Accelerate Cancer Research 5284 1Moffitt Cancer Center Joins National Campaign To Implore Americans To Donate 241 To Accelerate Cancer Research 5284 2Genaera Corporation Announces First Quarter Financial Results 5280 1Genaera Corporation Announces First Quarter Financial Results 5280 2Genaera Corporation Announces First Quarter Financial Results 5280 3Genaera Corporation Announces First Quarter Financial Results 5280 4Aerospace business leader supreme problem solver 18941 1Aerospace business leader supreme problem solver 18941 2
...lls Isolated from Females Regenerate Skeletal Musc...pril 09, 2007 /PRNewswire/ -- Female stem cells,de...rate skeletal,muscle tissue than male cells, accor...gh of UPMC. , The study, which is being published ...y, is the first ever to report a difference,in reg...
...y and MedImmune to Present Preclinical Data From S...IDGE, Mass. and GAITHERSBURG, Md., April 10, 2007 ... (Nasdaq:INFI) and,MedImmune, Inc. (Nasdaq:MEDI) t...with an oral formulation of IPI-504 in non-small,c...pcoming Annual,Meeting of the American Association...
Other Medicine Technology:The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 2The Sturdier Sex?: Study by Pittsburgh Scientists Finds Female Stem,Cells Work Better 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 2Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 3Infinity and MedImmune to Present Preclinical Data From Study of,Oral Formulation of IPI-504 At AACR 4
Flextend is a hydrocolloid skin barrier that is designed to be the most resistant to discharge and is the barrier of choice for urostomies and high output ileosotomies.
Inquire
Inquire
This remarkable anti-reflux valve is enclosed in a hard plastic housing which prevents the valve from being accidentally held closed when in sitting or reclining positions. The valve is virtually sel
Medicine Products: